Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
45 /100
MEDIUM RISK
Score updated Oct 13, 2026

PHIO — Phio Pharmaceuticals Corp. Dilution Risk Tracker

Track PHIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PHIO — Get alerts when the score changes →

As of October 13, 2026, Phio Pharmaceuticals Corp. (PHIO) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Phio Pharmaceuticals Corp. has a market capitalization of $10.71M, 11.62M shares outstanding, 25 institutional holders tracked. Stored dilution-related fields include 13.39M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
22
⚠️ Warrant Exposure
90
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 39%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 115% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.19 approaching $1 threshold
🔔 Track PHIO — Get forecast alerts →

Market Data

Market Cap$10.71M
Shares Outstanding11.62M
Float11.55M
Cash$21.00M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore45/100DilutionWatch score record
Shares Outstanding11.62MVerified float table or market cache
Public Float11.55MVerified float table or market cache
Market Cap$10.71MMarket data cache
Cash Runway25.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants13.39MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 108.2% shares (2026Q1 vs prior)
25 institutional holders · 760.6K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 159.7K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 147.3K shares
#3 JANE STREET GROUP, LLC 119.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest89.5K
Days to Cover1.0
% of Float0.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2023-03-22
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PHIO Dilution Snapshot

Phio Pharmaceuticals Corp. (PHIO) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PHIO's DilutionScore is currently 45/100 (Medium risk), with 5 score changes tracked over 89 days. The score improved from 35/100 (Medium risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202645/100MEDIUM16 days
Sep 17 – Sep 27, 202635/100MEDIUM11 days
Aug 22 – Sep 16, 202636/100MEDIUM26 days
Aug 14 – Aug 21, 202651/100HIGH7 days
Jul 17 – Aug 13, 202647/100MEDIUM28 days
Jul 16, 202648/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track PHIO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PHIO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PHIO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PHIO
PHIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.